Bueno-Hernández et al., 2019 - Google Patents
Review of the scientific evidence and technical opinion on noncaloric sweetener consumption in gastrointestinal diseasesBueno-Hernández et al., 2019
View HTML- Document ID
- 16284108852887354805
- Author
- Bueno-Hernández N
- Vázquez-Frías R
- y Abreu A
- Almeda-Valdés P
- Barajas-Nava L
- Carmona-Sánchez R
- Chávez-Sáenz J
- Consuelo-Sánchez A
- Espinosa-Flores A
- Hernández-Rosiles V
- Hernández-Vez G
- Icaza-Chávez M
- Noble-Lugo A
- Romo-Romo A
- Ruiz-Margaín A
- Valdovinos-Díaz M
- Zárate-Mondragón F
- Publication year
- Publication venue
- Revista de Gastroenterología de México (English Edition)
External Links
Snippet
The present review of noncaloric sweeteners (NCSs) by the Asociación Mexicana de Gastroenterología was carried out to analyze and answer some of the most frequent questions and concerns about NCS consumption in patients with gastrointestinal disorders …
- 235000013615 non-nutritive sweetener 0 title abstract description 73
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharide having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bueno-Hernández et al. | Review of the scientific evidence and technical opinion on noncaloric sweetener consumption in gastrointestinal diseases | |
| Nettleton et al. | Maternal low-dose aspartame and stevia consumption with an obesogenic diet alters metabolism, gut microbiota and mesolimbic reward system in rat dams and their offspring | |
| Basson et al. | Artificial sweeteners: history and new concepts on inflammation | |
| ES2290289T3 (en) | USE OF BINDING AGENTS AS AGENTS GENERATING SACIEDAD. | |
| Ruiz-Ojeda et al. | Effects of sweeteners on the gut microbiota: a review of experimental studies and clinical trials | |
| Romo-Romo et al. | Non-nutritive sweeteners: evidence on their association with metabolic diseases and potential effects on glucose metabolism and appetite | |
| Mooradian et al. | The role of artificial and natural sweeteners in reducing the consumption of table sugar: A narrative review | |
| Elia et al. | Physiological aspects of energy metabolism and gastrointestinal effects of carbohydrates | |
| Moriconi et al. | Neuroendocrine and metabolic effects of low-calorie and non-calorie sweeteners | |
| Mäkinen | Gastrointestinal disturbances associated with the consumption of sugar alcohols with special consideration of xylitol: scientific review and instructions for dentists and other health‐care professionals | |
| Rojas et al. | Stevia rebaudiana Bertoni and its effects in human disease: emphasizing its role in inflammation, atherosclerosis and metabolic syndrome | |
| Spencer et al. | Artificial sweeteners: a systematic review and primer for gastroenterologists | |
| ES2356536B1 (en) | A composition used as a prebiotic that contains a pomegranate extract and a food that includes said composition. | |
| BRPI0712087A2 (en) | methods of use and nutritional compositions of rouchi extract | |
| Gómez‐Fernández et al. | The complex relationship between metabolic syndrome and sweeteners | |
| Kakleas et al. | Nonalcoholic fatty liver disease, insulin resistance, and sweeteners: a literature review | |
| Cabral et al. | Artificial sweeteners as a cause of obesity: weight gain mechanisms and current evidence | |
| Cavagnari | Non-caloric sweeteners: specific characteristics and safety assessment | |
| Tiwaskar et al. | Clearing the myths around non-nutritive/noncaloric sweeteners: an efficacy and safety evaluation | |
| Sambra et al. | Acute responses of stevia and d-tagatose intake on metabolic parameters and appetite/satiety in insulin resistance | |
| ES2198126T3 (en) | USE OF D-TAGATOSE AS A PREBIOTIC FOOD COMPONENT. | |
| Bueno-Hernández et al. | REVISTA DE DE MEXICO | |
| Bueno-Hernández et al. | Association of natural and artificial nonnutritive sweeteners on gastrointestinal disorders: A narrative review | |
| Liu et al. | Deciphering the multifaceted effects of artificial sweeteners on body health and metabolic functions: a comprehensive review and future perspectives | |
| US7202219B1 (en) | Use of D-tagatose as a prebiotic food component |